Skip to main content
iwCLL 2023 Main banner
Final Program


iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Jennifer A. Woyach, MD

Professor of Medicine
Division of Hematology, Department of Internal Medicine, The Ohio State University
The Ohio State University Comprehensive Cancer Center
Columbus, OH, United States

Jennifer A Woyach, MD from The Ohio State University. Dr. Woyach is a tenured Professor in the Division of Hematology at The Ohio State University, with a focus on translational research in Chronic Lymphocytic Leukemia (CLL). She is the Associate Director for Clinical Research within the Division of Hematology, Section Head for the CLL/Hairy cell leukemia group, and Co-Director of the Leukemia Research Program within the OSU Comprehensive Cancer Center. She is the PI for multiple early stage clinical trials investigating novel targeted therapies for CLL and other hematologic malignancies, and also mentor junior faculty members in the development and conduct of Phase I studies. She chaired the intergroup Phase III study A041202 which investigated chemoimmunotherapy versus targeted therapy as initial therapy for older adults with CLL, and now chair A041702 which is investigating continuous versus intermittent targeted therapy in the same patient population. These studies are performed in the context of my role as a member of the Leukemia and Cancer in the Elderly Committees of the Alliance for Clinical Trials in Oncology. Her laboratory research focuses on resistance to targeted therapies in CLL, and using knowledge of resistance mechanisms to investigate novel treatments for CLL.

Presentation(s):

Email Jennifer